Last reviewed · How we verify
NCT05094986
Feasibility and Acceptability of a Complex Intervention to Improve Initial Medication Adherence
NA trial testing Initial Medication Adherence (IMA) Intervention in Adherence, Medication in 605 participants. Completed in 30 June 2021.
30 January 2021
Quick facts
| Lead sponsor | Fundació Sant Joan de Déu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 605 |
| Start date | 1 November 2020 |
| Primary completion | 30 January 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 5 locations across Spain |
Drugs / interventions tested
- Initial Medication Adherence (IMA) Intervention
- Usual Care
Conditions studied
- Adherence, Medication — all drugs for Adherence, Medication →
Sponsor
Fundació Sant Joan de Déu — full company profile →
Who can join
18 and older, any sex, with Adherence, Medication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study aims to test the feasibility of the following effectiveness and cost-effectiveness evaluation using Real-World Data.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Improving Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care: Pilot trial of a complex intervention.
Corral-Partearroyo C, Sánchez-Viñas A, Gil-Girbau M, Peñarrubia-María MT, et al · · 2022 · cited 7× · PMID 36561857 · DOI 10.3389/fpubh.2022.1038138 -
Complex multidisciplinary intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): mixed-methods process evaluation protocol.
Corral-Partearroyo C, Sánchez-Viñas A, Gil-Girbau M, Peñarrubia-María MT, et al · · 2022 · cited 5× · PMID 36316078 · DOI 10.1136/bmjopen-2022-067468
Verify or expand the search:
- PubMed search for NCT05094986
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adherence, Medication
Currently open trials in the same condition.
- NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study · NA · recruiting
- NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant · NA · recruiting
- NCT06056037 — Making ART Work Among Brazilian Youth · NA · recruiting
- NCT05619601 — Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction · active not recruiting
- NCT05374109 — SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth · NA · active not recruiting
Other Fundació Sant Joan de Déu trials
Trials by the same sponsor.
- NCT07508917 — Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation · Phase 1, PHASE2 · not yet recruiting
- NCT06556251 — Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme · NA · recruiting
- NCT06309121 — Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents · NA · active not recruiting
- NCT07091344 — Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis · NA · recruiting
- NCT06340555 — Intervention to Prevent Mental Health Disorders of Women and Their Partners Who Experienced Pregnancy Loss · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05094986 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundació Sant Joan de Déu
- Last refreshed: 18 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05094986.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing